Duration of smoking cessation in patients with inflammatory bowel disease.

Autor:	González-Muñoza C; Hospital Santa Creu i Sant Pau, Barcelona, Catalonia, Spain., Gely C; Hospital Santa Creu i Sant Pau, Barcelona, Catalonia, Spain., Gordillo J; Hospital Santa Creu i Sant Pau, Barcelona, Catalonia, Spain., Bertoletti F; Hospital Santa Creu i Sant Pau, Barcelona, Catalonia, Spain., Giordano A; Hospital Santa Creu i Sant Pau, Barcelona, Catalonia, Spain., López-Faba A; Hospital Santa Creu i Sant Pau, Barcelona, Catalonia, Spain., García-Planella E; Hospital Santa Creu i Sant Pau, Barcelona, Catalonia, Spain. Electronic address: egarciapl@santpau.cat.
Jazyk:	English; Spanish; Castilian
Zdroj:	Gastroenterologia y hepatologia [Gastroenterol Hepatol] 2024 Jun-Jul; Vol. 47 (6), pp. 591-597. Date of Electronic Publication: 2023 Nov 15.
DOI:	10.1016/j.gastrohep.2023.11.002
Abstrakt:	Background and Objectives: Smoking can worsen inflammatory bowel disease (IBD), although evidence regarding the duration of cessation is scarce. The objectives of the study were to determine the duration of abstinence and identify the characteristics of relapse in IBD patients. Patients and Methods: Using the local database of a nationwide registry of patients with IBD, we identified patients who were active smokers at the time of IBD diagnosis and invited them to participate in the study. Patients were asked about their smoking habit and those who were ex-smokers constituted the study cohort. We obtained clinical and smoking-related data of ex-smokers from medical records and telephone interviews. We measured nicotine dependence using the Fagerström Test for Nicotine Dependence (FTND). Results: We enrolled 121 IBD patients who were ex-smokers: 89 patients with Crohn's disease (CD) and 33 patients with ulcerative colitis (UC). The median age at cessation was lower in patients with CD (38 years) than in patients with UC (46 years) (p=0.002). Follow-up time was shorter in CD patients than in UC patients (114 vs. 168 months, p=0.035). No difference was found in the FTND score. Relapse was more common in CD patients (46%) than in UC patients (24%) (p=0.029), although time to first relapse was similar in both groups of patients (12 and 15 months, respectively; p=0.056). Nicotine dependence was the only independent factor associated with relapse. Conclusions: The risk of smoking relapse was high, especially in CD patients, although their dependence level was similar to that of UC patients. (Copyright © 2023 Elsevier España, S.L.U. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu